A quality growth stock to buy on the recovery

Growth stocks have faced a torrid time in 2022, due to macroeconomic pressures. Here’s one I think has been unfairly beaten down.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Hand of person putting wood cube block with word VALUE on wooden table

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Unlike during the pandemic, 2022 has not been a good year for growth stocks. For example, the Nasdaq, which is home to many of these growth stocks, has sunk 24% year-to-date and by 12% in the past year. This has been due to the macroeconomic issues, including rising inflation and higher interest rates.

Consequently, investors have been pulling out of growth stocks, instead favouring value and income stocks. But as a long-term investor, I believe that this dip has offered an opportunity in many great companies, trading at historically low prices.

After Salesforce (NYSE: CRM) released its promising trading update on Tuesday evening, I’d buy more of this cloud-based software company. 

The recent trading update 

Despite the macroeconomic headwinds, Salesforce was able to achieve strong growth in the first quarter of 2022. For example, it delivered revenue of $7.41bn, which was up 24% year-on-year, while operating cash flow increased 14% year-on-year to $3.68bn.

Further, the group has $42bn in all future revenue under contract, which provides the firm with very strong visibility moving forward. However, the Salesforce stock price is still down 30% in the past year, which seems out of touch with the company’s performance.

These results also highlighted that demand remained strong and consumers were continuing to use the firm’s consumer relationship management services. Therefore I’m optimistic that, unlike many other growth stocks, the company has managed to deal well with the inflationary problems. 

In the greatest sign of this strength, Salesforce increased its adjusted profit estimate for the fiscal year to $4.75 per share, up from previous forecasts of $4.63. This has been down to “disciplined decision-making”, which has allowed the firm to expand operating margins. In the current macroeconomic environment, signs that the firm is increasing profit margins demonstrates its quality. 

Some of the drawbacks

Despite this excellent trading update, Salesforce is not immune to the problems facing other growth stocks. For example, the company has had to cut revenue guidance. Therefore, revenue for the full year is now expected to total around $31.75bn, down from expectations of $32bn.

Although it has been attributed to volatility in exchange rates, it may be a sign of slowing growth. This could have negative impacts. 

There is also a risk that as inflation continues to soar, companies will have to cut costs further. This may lead them to cancelling subscriptions with Salesforce altogether, or spending less. Although the contracted revenues help mitigate this worry, it remains a risk that requires consideration. 

What am I doing with this growth stock? 

I already own Salesforce shares and, at these prices, I’m tempted to add more. Indeed, although a price-to-earnings ratio of 35 is not typically considered a bargain, it is historically low for Salesforce. In fact, in the past five years, it has had an average P/E ratio of over 200.

As the firm focuses on its profitability, I feel there is scope for increasing profits in the next few years. Therefore, I would certainly add more Salesforce shares to my portfolio. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Stuart Blair owns shares in Salesforce, Inc. The Motley Fool UK has recommended Salesforce, Inc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

8.6% or 7.2%? Does the Legal & General or Aviva dividend look better?

The Aviva dividend tempts our writer. But so does the payout from Legal & General. Here he explains why he'd…

Read more »

a couple embrace in front of their new home
Investing Articles

Are Persimmon shares a bargain hiding in plain sight?

Persimmon shares have struggled in 2024, so far. But today's trading update suggests sentiment in the housing market's already improving.

Read more »

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »

Investing Articles

Barclays’ share price jumps 5% on Q1 news. Will it soon be too late to buy?

The Barclays share price has been having a great time this year, as a solid Q1 gives it another boost.…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

The AstraZeneca share price lifts 5% on a top-and-bottom earnings beat

The AstraZeneca share price reached £120 today and helped push the FTSE 100 higher. Would I still buy this flying…

Read more »

Young black woman using a mobile phone in a transport facility
Market Movers

Meta stock slumps 13% after poor results. Here’s what I’ll do

Jon Smith flags up the reasons behind the fall in the Meta stock price overnight, along with his take on…

Read more »

Young Caucasian girl showing and pointing up with fingers number three against yellow background
Investing Articles

3 FTSE stocks I wouldn’t ‘Sell in May’

If the strategy had any merit in the past, I see no compelling evidence it's a smart idea today. Here…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

Down 21% and yielding 10%, is this income stock a top contrarian buy now?

Despite its falling share price, this Fool reckons he's found an income stock that could be worth taking a closer…

Read more »